OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
Rhea-AI Summary
OraSure Technologies (NASDAQ: OSUR) will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market close. The company will host a conference call to discuss the results at 5:00 p.m. Eastern Time the same day, with a live webcast available via its investor relations website.
According to OraSure, investors can access the webcast by registering through the events and presentations section of its site at least 10 minutes before the call. An archived version of the webcast will be available on the website for approximately one year.
Positive
- None.
Negative
- None.
News Market Reaction – OSUR
In the Jul 23 session, OSUR gained 6.33%, reflecting a notable positive market reaction. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 22 | Earnings date | Neutral | -2.2% | Scheduled Q1 2026 results and conference call preceded a -2.24% 24-hour move. |
| Feb 09 | Earnings date | Neutral | -0.3% | Scheduled Q4 2025 results and conference call preceded a -0.35% 24-hour move. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
OraSure's prior earnings-date announcements were followed by negative 24-hour reactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market closes. It will hold its quarterly conference call to discuss the results beginning at 5 p.m. Eastern Time on that day.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately one year.
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure” and “OTI”) transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. OTI improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its wholly-owned subsidiaries, DNA Genotek Inc., Sherlock Biosciences, Inc., and BioMedomics, Inc., OTI is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OTI’s portfolio of products is sold globally to clinical laboratories, hospitals, physicians’ offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information, please visit www.orasure.com.
| Investor Contact: | Media Contact: |
| investorinfo@orasure.com | media@orasure.com |
